CD7 CAR T Cells (RD13-02)

CD7 CAR T cells · Institute of Hematology & Blood Diseases Hospital, China

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CD7 CAR T Cells (RD13-02), covering 2025-07-24 to 2025-07-24. Get the full timeline:

Most recent: Clinical Trial Update: CD7 CAR T Cells (RD13-02) in the Treatment of Relapsed/Refractory Severe Aplastic Anemia [Phase 1]